Look back at pharma news to Nov 11

Investors in the beaten down biotech sector finally got an unexpected reprieve this week, thanks mainly due to the unexpected "clean sweep" of the US Congress and the presidency by the  Republican party, wrote Bret Jensen on the Seeking Alpha blog.

This was an outcome that was expected by very few, if any, mainstream pundits. The results have triggered a huge rally, another unexpected result, as the consensus was that the market would have a substantial sell-off if Donald Trump was elected.

We have seen a huge sector rotation within equities as investors have piled into sectors like energy and financials that borne the brunt of the outgoing administration's regulatory efforts. Pharma and biotech have also seen huge bounces, as worry about new legislation and regulations around drug pricing has disappeared, said Mr Jensen.